Get started
RHYTHM PHARMACEUTICALS INCRHYTHM PHARMACEUTICALS INCRHYTHM PHARMACEUTICALS INC

RHYTHM PHARMACEUTICALS INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

RYTM chart


Full chart

RYTM upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪65.21 B‬ MXN
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−80.09 MXN
Net income (FY)
‪−3.14 B‬ MXN
Revenue (FY)
‪1.32 B‬ MXN
Shares float
‪54.57 M‬
Beta (1Y)
1.75

Employees


Employees (FY)
226
Change (1Y)
+49 +27.68%
Revenue / Employee (1Y)
‪342.60 K‬ MXN
Net income / Employee (1Y)
‪−817.16 K‬ MXN

About Rhythm Pharmaceuticals, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
David P. Meeker
Website
rhythmtx.com
Headquarters
Boston
Founded
2008
FIGI
BBG00PGH17C9
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases. It is also involved in the clinical development program for setmelanotide in other rare MC4R pathway diseases, as well as a preclinical suite of investigational candidates for the treatment of congenital hyperinsulinism. The company was founded by Bart Henderson in November 2008 and is headquartered in Boston, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

RYTM news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of RYTM is 958.00 MXN — it has decreased by −2.93% in the past 24 hours. Watch RHYTHM PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange RHYTHM PHARMACEUTICALS INC stocks are traded under the ticker RYTM.
RYTM stock has fallen by −2.93% compared to the previous week, the month change is a 40.84% rise, over the last year RHYTHM PHARMACEUTICALS INC has showed a 105.46% increase.
We've gathered analysts' opinions on RHYTHM PHARMACEUTICALS INC future price: according to them, RYTM price has a max estimate of 1,529.57 MXN and a min estimate of 1,032.96 MXN. Watch RYTM chart and read a more detailed RHYTHM PHARMACEUTICALS INC stock forecast: see what analysts think of RHYTHM PHARMACEUTICALS INC and suggest that you do with its stocks.
RYTM reached its all-time high on Oct 22, 2024 with the price of 986.88 MXN, and its all-time low was 124.00 MXN and was reached on Feb 14, 2022. View more price dynamics on RYTM chart.
See other stocks reaching their highest and lowest prices.
RYTM stock is 3.01% volatile and has beta coefficient of 1.75. Track RHYTHM PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is RHYTHM PHARMACEUTICALS INC there?
Today RHYTHM PHARMACEUTICALS INC has the market capitalization of ‪65.21 B‬, it has increased by 1.48% over the last week.
Yes, you can track RHYTHM PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
RHYTHM PHARMACEUTICALS INC is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
RYTM earnings for the last quarter are −14.38 MXN per share, whereas the estimation was −15.85 MXN resulting in a 9.27% surprise. The estimated earnings for the next quarter are −15.94 MXN per share. See more details about RHYTHM PHARMACEUTICALS INC earnings.
RHYTHM PHARMACEUTICALS INC revenue for the last quarter amounts to ‪655.17 M‬ MXN, despite the estimated figure of ‪640.82 M‬ MXN. In the next quarter, revenue is expected to reach ‪721.73 M‬ MXN.
RYTM net income for the last quarter is ‪−591.73 M‬ MXN, while the quarter before that showed ‪−2.34 B‬ MXN of net income which accounts for 74.74% change. Track more RHYTHM PHARMACEUTICALS INC financial stats to get the full picture.
No, RYTM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 6, 2024, the company has 226.00 employees. See our rating of the largest employees — is RHYTHM PHARMACEUTICALS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RHYTHM PHARMACEUTICALS INC EBITDA is ‪−4.84 B‬ MXN, and current EBITDA margin is −235.83%. See more stats in RHYTHM PHARMACEUTICALS INC financial statements.
Like other stocks, RYTM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RHYTHM PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RHYTHM PHARMACEUTICALS INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RHYTHM PHARMACEUTICALS INC stock shows the buy signal. See more of RHYTHM PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.